Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for analgesia in isolated limb trauma
IRCT20251028067801N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute pain comparing Ketorolac group with Dexmedetomidine group (2 arms). Primary endpoints: Pain and Agitation. Started Dec 2025; status: completed.
02
Drugs
dexmedetomidineketorolac
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20251028067801N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251028067801N1.